FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.9  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)

Status: current, Primitive. Date: 31-Jan 2002. Module: SNOMED CT model component

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Case sensitive SNOMED CT model component
900000000001157018 REPLACED BY association reference set en Synonym Active Case sensitive SNOMED CT model component

131244 members. Search Members:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set Is a Historical association true Inferred relationship Some
Members associationTargetComponent
chlorhexidine gluconate 1% lotion, 500 mL chlorhexidine gluconate 1% + ethanol 70% lotion, 500 mL
chlorhexidine gluconate 4% application, 50 mL tube chlorhexidine gluconate 4% solution, 50 mL tube
chlorhexidine gluconate 4% application, 20 x 50 mL tubes chlorhexidine gluconate 4% solution, 20 x 50 mL tubes
chlorhexidine gluconate 4% application, tube chlorhexidine gluconate 4% solution, tube
chlorhexidine gluconate 2 mg / 1 mL + sodium fluoride 33 microgram / 1 mL oral gel (medicinal product unit of use) Unknown Cell Type 2
chlorhexidine gluconate 2 mg / 1 mL + sodium fluoride 33 microgram / 1 mL oral gel, 30 mL (medicinal product pack) Unknown Cell Type 2
chlorhexidine gluconate 2% application chlorhexidine gluconate 2% solution
chlorhexidine gluconate 2% application, 750 mL chlorhexidine gluconate 2% solution, 750 mL
chlorhexidine gluconate 3 mg / 1 g + phenylephrine hydrochloride 2.5 mg / 1 g nasal cream (medicinal product unit of use) Unknown Cell Type 2
chlorhexidine gluconate 3 mg / 1 g + phenylephrine hydrochloride 2.5 mg / 1 g nasal cream, 15 g (medicinal product pack) Unknown Cell Type 2
chlorhexidine gluconate 4% application chlorhexidine gluconate 4% solution
chlorhexidine gluconate 4% application, 1.5 L chlorhexidine gluconate 4% solution, 1.5 L
chlorhexidine gluconate 4% application, 125 mL chlorhexidine gluconate 4% solution, 125 mL
chlorhexidine gluconate 4% application, 5 L chlorhexidine gluconate 4% solution, 5 L
chlorhexidine gluconate 4% application, 500 mL chlorhexidine gluconate 4% solution, 500 mL
chlorhexidine gluconate 0.5% + ethanol 58.13% application chlorhexidine gluconate 0.5% + ethanol 58.13% solution
chlorhexidine gluconate 0.5% + ethanol 58.13% application, 125 mL chlorhexidine gluconate 0.5% + ethanol 58.13% solution, 125 mL
chlorhexidine gluconate 0.5% + ethanol 58.13% application, 500 mL chlorhexidine gluconate 0.5% + ethanol 58.13% solution, 500 mL
chlorhexidine gluconate 0.5% + ethanol 70% solution chlorhexidine gluconate 0.5% + ethanol 70% solution
chlorhexidine gluconate 0.5% + ethanol 70% solution, 125 mL chlorhexidine gluconate 0.5% + ethanol 70% solution, 125 mL
chlorhexidine gluconate 0.5% + ethanol 70% solution, 500 mL chlorhexidine gluconate 0.5% + ethanol 70% solution, 500 mL
chlorhexidine hydrochloride 1% + hexamidine isethionate 0.15% + allantoin 0.25% dusting powder Unknown Cell Type 2
chlorhexidine hydrochloride 1% + hexamidine isethionate 0.15% + allantoin 0.25% dusting powder, 12.5 g Unknown Cell Type 2
chlorhexidine hydrochloride 1% + hexamidine isethionate 0.15% + allantoin 0.25% dusting powder, 25 g Unknown Cell Type 2
chlorhexidine hydrochloride 1% + hexamidine isetionate 0.15% + allantoin 0.25% dusting powder Unknown Cell Type 2
chlorhexidine hydrochloride 1% + hexamidine isetionate 0.15% + allantoin 0.25% dusting powder, 12.5 g Unknown Cell Type 2
chlorhexidine hydrochloride 1% + hexamidine isetionate 0.15% + allantoin 0.25% dusting powder, 25 g Unknown Cell Type 2
chlorhexidine hydrochloride 2.5 mg / 1 g + tolnaftate 10 mg / 1 g dusting powder (medicinal product unit of use) Unknown Cell Type 2
chlorhexidine hydrochloride 2.5 mg / 1 g + tolnaftate 10 mg / 1 g dusting powder, 55 g (medicinal product pack) Unknown Cell Type 2
pseudoephedrine hydrochloride 60 mg + chlorphenamine maleate 4 mg tablet pseudoephedrine sulfate 60 mg + chlorphenamine maleate 4 mg tablet
pseudoephedrine hydrochloride 60 mg + chlorphenamine maleate 4 mg tablet, 12 pseudoephedrine sulfate 60 mg + chlorphenamine maleate 4 mg tablet, 12
pseudoephedrine hydrochloride 60 mg + chlorphenamine maleate 4 mg tablet, 4 pseudoephedrine sulfate 60 mg + chlorphenamine maleate 4 mg tablet, 4
chlorphenesin 10 mg / 1 g + maize starch 558.5 mg / 1 g + purified talc 180.7 mg / 1 g + zinc oxide 250 mg / 1 g dusting powder (medicinal product unit of use) Unknown Cell Type 2
chlorphenesin 10 mg / 1 g + maize starch 558.5 mg / 1 g + purified talc 180.7 mg / 1 g + zinc oxide 250 mg / 1 g dusting powder, 100 g (medicinal product pack) Unknown Cell Type 2
codeine phosphate hemihydrate 6 mg + paracetamol 500 mg + phenylephrine hydrochloride 5 mg tablet [8] (&) chlorpheniramine maleate 2 mg + paracetamol 500 mg + phenylephrine hydrochloride 5 mg tablet [16], 24 paracetamol 500 mg + codeine phosphate hemihydrate 6 mg + phenylephrine hydrochloride 5 mg tablet [16] (&) phenylephrine hydrochloride 5 mg + paracetamol 500 mg + chlorphenamine maleate 2 mg tablet [8], 24
cholera (Vibrio cholerae) O1 Inaba El Tor strain inactivated oral vaccine Vibrio cholerae O1 inactivated antigen
cholera (Vibrio cholerae) O1 Inaba classic strain inactivated oral vaccine Vibrio cholerae O1 inactivated antigen
cholera (Vibrio cholerae) O1 Ogawa classic strain inactivated oral vaccine Vibrio cholerae O1 inactivated antigen
cholera toxin B subunit recombinant oral vaccine cholera toxin B subunit
cholera (Vibrio cholerae) O1 Inaba classic strain inactivated oral vaccine + cholera (Vibrio cholerae) O1 Inaba El Tor strain inactivated oral vaccine + cholera (Vibrio cholerae) O1 Ogawa classic strain inactivated oral vaccine + cholera toxin B subunit recombinant oral vaccine cholera vaccine
cholera (Vibrio cholerae) O1 Inaba classic strain inactivated oral vaccine 25 billion vibrios + cholera (Vibrio cholerae) O1 Inaba El Tor strain inactivated oral vaccine 25 billion vibrios + cholera (Vibrio cholerae) O1 Ogawa classic strain inactivated oral vaccine 50 billion vibrios + cholera toxin B subunit recombinant oral vaccine 1 mg oral liquid [ 1 x 3 mL vial] (&) inert substance powder for oral liquid [1 x 5.6 g sachet], 1 pack cholera vaccine oral liquid [3 mL vial] (&) inert substance effervescent granules [5.6 g sachet], 1 pack
cholera (Vibrio cholerae) O1 Inaba classic strain inactivated oral vaccine 25 billion vibrios + cholera (Vibrio cholerae) O1 Inaba El Tor strain inactivated oral vaccine 25 billion vibrios + cholera (Vibrio cholerae) O1 Ogawa classic strain inactivated oral vaccine 50 billion vibrios + cholera toxin B subunit recombinant oral vaccine 1 mg oral liquid [2 x 3 mL vials] (&) inert substance powder for oral liquid [2 x 5.6 g sachets], 1 pack cholera vaccine oral liquid [2 x 3 mL vials] (&) inert substance effervescent granules [2 x 5.6 g sachets], 1 pack
cholera (Vibrio cholerae) O1 Inaba classic strain inactivated oral vaccine 25 billion vibrios + cholera (Vibrio cholerae) O1 Inaba El Tor strain inactivated oral vaccine 25 billion vibrios + cholera (Vibrio cholerae) O1 Ogawa classic strain inactivated oral vaccine 50 billion vibrios + cholera toxin B subunit recombinant oral vaccine 1 mg oral liquid, 3 mL vial cholera vaccine oral liquid, 3 mL vial
choline salicylate 8.7% + menthol 0.057% + cetalkonium chloride 0.01% oral gel Unknown Cell Type 2
choline salicylate 8.7% + menthol 0.057% + cetalkonium chloride 0.01% oral gel, 15 g Unknown Cell Type 2
choline salicylate 8.7% + menthol 0.057% + cetalkonium chloride 0.01% oral gel, 30 g Unknown Cell Type 2
choline salicylate 8.7% oral gel Unknown Cell Type 2
choline salicylate 8.7% oral gel, 15 g Unknown Cell Type 2
choline salicylate 8.7% oral gel, 20 g Unknown Cell Type 2
choline salicylate 8.7% oral gel, 30 g Unknown Cell Type 2
choline salicylate 87 mg / 1 g oral gel (medicinal product unit of use) Unknown Cell Type 2
choline salicylate 87 mg / 1 g oral gel, 15 g (medicinal product pack) Unknown Cell Type 2
choline salicylate 87 mg / 1 g oral gel, 20 g (medicinal product pack) Unknown Cell Type 2
choline salicylate 87 mg / 1 g oral gel, 30 g (medicinal product pack) Unknown Cell Type 2
choline salicylate 9% + benzalkonium chloride 0.01% + ethanol 31.7% oral gel Unknown Cell Type 2
choline salicylate 9% + benzalkonium chloride 0.01% + ethanol 31.7% oral gel Unknown Cell Type 2
choline salicylate 9% + benzalkonium chloride 0.01% + ethanol 31.7% oral gel, 10 g Unknown Cell Type 2
choline salicylate 9% + benzalkonium chloride 0.01% + ethanol 31.7% oral gel, 10 g Unknown Cell Type 2
choline salicylate 9% + ethanol 35% + cetylpyridinium chloride 0.0375% + cetalkonium chloride 0.025% oral gel Unknown Cell Type 2
choline salicylate 9% + ethanol 35% + cetylpyridinium chloride 0.0375% + cetalkonium chloride 0.025% oral gel, 15 g Unknown Cell Type 2
choline salicylate 9% + ethanol 35% + cetylpyridinium chloride monohydrate 0.0375% + cetalkonium chloride 0.025% oral gel Unknown Cell Type 2
choline salicylate 9% + ethanol 35% + cetylpyridinium chloride monohydrate 0.0375% + cetalkonium chloride 0.025% oral gel, 15 g Unknown Cell Type 2
chondroitin sulfate sodium 40 mg/mL + hyaluronate sodium 30 mg/mL intraocular injection, 0.5 mL syringe sodium chondroitin sulfate 40 mg/mL + hyaluronate sodium 30 mg/mL intraocular injection, syringe
chondroitin sulfate sodium 40 mg/mL + hyaluronate sodium 30 mg/mL intraocular injection, 0.5 mL syringe sodium chondroitin sulfate 40 mg/mL + hyaluronate sodium 30 mg/mL intraocular injection, 0.5 mL syringe
choriogonadotropin alfa 250 microgram/0.5 mL injection, cartridge choriogonadotropin alfa 250 microgram/0.5 mL injection, pen device
choriogonadotropin alfa 250 microgram / 0.5 mL injection, 0.5 mL injection device (medicinal product unit of use) Unknown Cell Type 2
choriogonadotropin alfa 250 microgram/0.5 mL injection, 1 dose choriogonadotropin alfa 250 microgram/0.5 mL injection, 0.5 mL pen device
choriogonadotropin alfa 250 microgram/0.5 mL injection, 0.5 mL cartridge choriogonadotropin alfa 250 microgram/0.5 mL injection, 0.5 mL pen device
choriogonadotropin alfa 250 microgram / 0.5 mL injection, 1 x 0.5 mL injection device (medicinal product pack) Unknown Cell Type 2
choriogonadotropin alfa 250 microgram / 0.5 mL injection, dose (medicinal product unit of use) choriogonadotropin alfa 250 microgram/0.5 mL injection, pen device
choriogonadotropin alfa 250 microgram/0.5 mL injection, 0.5 mL injection device Unknown Cell Type 2
choriogonadotropin alfa 250 microgram/0.5 mL injection, injection device Unknown Cell Type 2
cupric chloride dihydrate + chromic chloride hexahydrate + manganese chloride tetrahydrate copper + chromium + manganese
ciclesonide 160 microgram / 1 actuation pressurised inhalation, 120 actuations (medicinal product pack) Unknown Cell Type 2
ciclesonide 160 microgram / 1 actuation pressurised inhalation, 60 actuations (medicinal product pack) Unknown Cell Type 2
ciclesonide 160 microgram / 1 actuation pressurised inhalation, actuation (medicinal product unit of use) Unknown Cell Type 2
ciclesonide 160 microgram/actuation pressurised inhalation, 120 actuations Unknown Cell Type 2
ciclesonide 160 microgram/actuation pressurised inhalation, 60 actuations Unknown Cell Type 2
ciclesonide 160 microgram/actuation pressurised inhalation, actuation Unknown Cell Type 2
ciclesonide 40 microgram / 1 actuation pressurised inhalation, 120 actuations (medicinal product pack) Unknown Cell Type 2
ciclesonide 40 microgram / 1 actuation pressurised inhalation, actuation (medicinal product unit of use) Unknown Cell Type 2
ciclesonide 40 microgram/actuation pressurised inhalation, 120 actuations Unknown Cell Type 2
ciclesonide 40 microgram/actuation pressurised inhalation, actuation Unknown Cell Type 2
ciclesonide 80 microgram / 1 actuation pressurised inhalation, 120 actuations (medicinal product pack) Unknown Cell Type 2
ciclesonide 80 microgram / 1 actuation pressurised inhalation, 60 actuations (medicinal product pack) Unknown Cell Type 2
ciclesonide 80 microgram / 1 actuation pressurised inhalation, actuation (medicinal product unit of use) Unknown Cell Type 2
ciclesonide 80 microgram/actuation pressurised inhalation, 120 actuations Unknown Cell Type 2
ciclesonide 80 microgram/actuation pressurised inhalation, 60 actuations Unknown Cell Type 2
ciclesonide 80 microgram/actuation pressurised inhalation, actuation Unknown Cell Type 2
ciclopirox 8% application ciclopirox 8% solution
ciclopirox 80 mg / 1 g application, 3.3 mL (medicinal product pack) ciclopirox 8% solution, 3.3 mL
ciclopirox 8% application, 6.6 mL ciclopirox 8% solution, 6.6 mL
ciclosporin 1% eye drops, unit dose ciclosporin 0.1% eye drops, unit dose
ciclosporin 1% eye drops, 30 x 1 mL unit doses ciclosporin 0.1% eye drops, 30 x 0.3 mL unit doses
citrate monohydrate 300 mg / 62.5 mL + glucose monohydrate 1 g / 62.5 mL + potassium citrate monohydrate 137.5 mg / 62.5 mL + sodium chloride 156.2 mg / 62.5 mL oral liquid for freezing, 16 x 62.5 mL sachets (medicinal product pack) Unknown Cell Type 2
citrate monohydrate 300 mg / 62.5 mL + glucose monohydrate 1 g / 62.5 mL + potassium citrate monohydrate 137.5 mg / 62.5 mL + sodium chloride 156.2 mg / 62.5 mL oral liquid for freezing, 62.5 mL sachet (medicinal product unit of use) Unknown Cell Type 2
citrate trisodium 1167.5 mg/2.5 mL solution, 2 x 2.5 mL syringes sodium citrate 1167.5 mg/2.5 mL solution, 2 x 2.5 mL syringes
citrate trisodium 1167.5 mg/2.5 mL solution, syringe sodium citrate 1167.5 mg/2.5 mL solution, syringe
sodium chloride + potassium citrate monohydrate + glucose + citric acid sodium chloride + potassium citrate + glucose + citric acid
sodium chloride + potassium chloride + glucose monohydrate + citric acid sodium chloride + potassium chloride + glucose + citric acid
magnesium + citric acid magnesium carbonate + citric acid

Start Previous Page 1286 of 1313 Next End

Reference Sets

Australian dialect reference set

Unit of use quantity reference set

Reference set descriptor

Back to Start